drugset / Trial / NCT01254461

A Drug-Drug Interaction Study Between AZD1981 and Pravastatin to Study the Effect of AZD1981 on the Kinetics of Pravastatin

NCT01254461

Phase 1 Completed 30 enrolled AstraZeneca
RandomizedParallel-groupOpen-labelBasic science

Summary

The primary purpose of this study is to determine whether the treatment with AZD1981 will affect the pharmacokinetics of pravastatin.

Timeline

Start
2011-02
Primary completion
2011-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD1981 Small molecule 100 mg Oral
Subject AZD1981 Small molecule 400 mg Oral
Subject Pravastatin Small molecule 40 mg

Indications

No indication recorded.